| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |